Dare Bioscience, Inc. Convertible Preferred Stock Converted to Other Securities
Dare Bioscience, Inc. (DARE) reported Convertible Preferred Stock Converted to Other Securities of $81.53 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities · last filed 2015-03-19
- Dare Bioscience, Inc. convertible preferred stock converted to other securities for fiscal 2014 was $81.53M, a 3562.44% increase from fiscal 2013.
- Dare Bioscience, Inc. convertible preferred stock converted to other securities for fiscal 2013 was $2.23M.
| Period end | Convertible Preferred Stock Converted to Other Securities 12 month |
|---|---|
| 2014-12-31 | $81.53M 10-K · filed 2015-03-19 |
| 2013-12-31 | $2.23M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |